According to a newly published market research report by 24LifeSciences, global Periodic Fever Syndrome market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period 2025-2031. Periodic Fever Syndromes represent a group of rare autoinflammatory disorders characterized by...

The global rare neurological disease treatment market is witnessing substantial growth due to increasing awareness regarding rare neurological disorders, rising investments in orphan drug development, and rapid advancements in biotechnology and precision medicine. Rare neurological diseases are complex disorders that affect the brain, spinal cord, nerves, and muscles, often leading to severe...